Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,400,000 shares, a growth of 32.1% from the December 15th total of 1,060,000 shares. Based on an average trading volume of 265,100 shares, the short-interest ratio is presently 5.3 days.
Analyst Ratings Changes
A number of equities research analysts recently commented on TCMD shares. BTIG Research lowered Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. StockNews.com lowered Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Finally, B. Riley assumed coverage on shares of Tactile Systems Technology in a research report on Thursday, September 26th. They set a “buy” rating and a $23.00 price target on the stock.
Read Our Latest Research Report on TCMD
Institutional Investors Weigh In On Tactile Systems Technology
Tactile Systems Technology Price Performance
Shares of Tactile Systems Technology stock traded down $0.06 during midday trading on Thursday, reaching $17.43. The company had a trading volume of 218,936 shares, compared to its average volume of 199,461. The company has a current ratio of 4.37, a quick ratio of 3.80 and a debt-to-equity ratio of 0.12. The stock has a fifty day simple moving average of $17.38 and a 200 day simple moving average of $14.75. Tactile Systems Technology has a 1-year low of $11.12 and a 1-year high of $21.10. The company has a market capitalization of $418.27 million, a price-to-earnings ratio of 26.82 and a beta of 1.21.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Further Reading
- Five stocks we like better than Tactile Systems Technology
- Golden Cross Stocks: Pattern, Examples and Charts
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- The 3 Best Fintech Stocks to Buy Now
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.